Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Income from Continuing Operations (2018 - 2025)

Arcturus Therapeutics Holdings (ARCT) has disclosed Income from Continuing Operations for 8 consecutive years, with 29079000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Income from Continuing Operations rose 3.09% year-over-year to 29079000.0, compared with a TTM value of 65783000.0 through Dec 2025, up 18.73%, and an annual FY2025 reading of 65783000.0, up 18.73% over the prior year.
  • Income from Continuing Operations was 29079000.0 for Q4 2025 at Arcturus Therapeutics Holdings, down from 13448000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 118642000.0 in Q4 2022 and bottomed at 57666000.0 in Q1 2021.
  • Average Income from Continuing Operations over 5 years is 18436400.0, with a median of 24190000.0 recorded in 2022.
  • The sharpest move saw Income from Continuing Operations crashed 509.45% in 2021, then skyrocketed 415.16% in 2022.
  • Year by year, Income from Continuing Operations stood at 37645000.0 in 2021, then surged by 415.16% to 118642000.0 in 2022, then plummeted by 109.84% to 11680000.0 in 2023, then crashed by 156.89% to 30005000.0 in 2024, then increased by 3.09% to 29079000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for ARCT at 29079000.0 in Q4 2025, 13448000.0 in Q3 2025, and 9180000.0 in Q2 2025.